GlassScriptPhysician profile
Danielle R Seiler
NPI 1881982890
$3,443.29
in general payments reported to CMS, 2019-2025
23 companies · $447 in 2025
The $447 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,000 · 2020: $431 · 2021: $140 · 2022: $227 · 2023: $59.70 · 2024: $138 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $644.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,288.43 | 2019-2025 | Affinity, Via Matrix |
| Kerecis Limited | $369.41 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Stryker Corporation | $244.87 | 2019-2020 | |
| Paragon 28, INC. | $242.36 | 2019 | |
| Wright Medical Technology, INC. | $200.88 | 2019-2020 | |
| Depuy Synthes Sales INC. | $149.03 | 2019 | |
| Liberty Surgical INC. | $148.58 | 2019 | |
| Zimmer Biomet Holdings, INC. | $138.15 | 2019 | |
| Biopro, INC. | $118.85 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $109.07 | 2019 | |
| Djo, LLC | $84.17 | 2019 | |
| Smith+Nephew, INC. | $74.28 | 2021-2024 | Grafix Pl, Regranex, Collagenase Santyl |
| Next Science LLC | $43.51 | 2023 | Xperience, Surgx, Blastx |
| Integra Lifesciences Corporation | $37.07 | 2019 | |
| Crossroads Extremity Systems, LLC | $35.10 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $31.91 | 2024 | |
| Avanos Medical | $24.54 | 2019 | |
| Orthofix Medical, INC. | $21.13 | 2024 | Physio-Stim |
| Kci USA, INC. | $20.92 | 2022 | |
| Solventum Corporation | $19.90 | 2025 | Promogran Prisma, Activ.A.C. |
| Paratek Pharmaceuticals, INC. | $15.15 | 2025 | Nuzyra |
| Averitas Pharma INC. | $13.57 | 2024 | Qutenza |
| Hikma Pharmaceuticals USA | $12.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Seiler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.